Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020.
Jason R GantenbergRobertus van AalstNicole M ZimmermanBrendan LimoneSandra S ChavesWilliam V La ViaChristopher B NelsonChristopher RizzoDavid A SavitzAndrew R ZulloPublished in: The Journal of infectious diseases (2022)
Term infants without known comorbidities account for up to 80% of the MA RSV LRTI burden in the United States during infants' first RSV season. Future prevention efforts should consider all infants.